187 related articles for article (PubMed ID: 22590553)
1. An in vivo cis-regulatory screen at the type 2 diabetes associated TCF7L2 locus identifies multiple tissue-specific enhancers.
Savic D; Bell GI; Nobrega MA
PLoS One; 2012; 7(5):e36501. PubMed ID: 22590553
[TBL] [Abstract][Full Text] [Related]
2. In vitro scan for enhancers at the TCF7L2 locus.
Savic D; Park SY; Bailey KA; Bell GI; Nobrega MA
Diabetologia; 2013 Jan; 56(1):121-5. PubMed ID: 23011354
[TBL] [Abstract][Full Text] [Related]
3. Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism.
Savic D; Ye H; Aneas I; Park SY; Bell GI; Nobrega MA
Genome Res; 2011 Sep; 21(9):1417-25. PubMed ID: 21673050
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of TCF7L2 genetic variants associated with type 2 diabetes.
Pang DX; Smith AJ; Humphries SE
Nutr Metab Cardiovasc Dis; 2013 Jun; 23(6):550-6. PubMed ID: 22402060
[TBL] [Abstract][Full Text] [Related]
5. A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell.
Kulzer JR; Stitzel ML; Morken MA; Huyghe JR; Fuchsberger C; Kuusisto J; Laakso M; Boehnke M; Collins FS; Mohlke KL
Am J Hum Genet; 2014 Feb; 94(2):186-97. PubMed ID: 24439111
[TBL] [Abstract][Full Text] [Related]
6. TCF7L2 is a master regulator of insulin production and processing.
Zhou Y; Park SY; Su J; Bailey K; Ottosson-Laakso E; Shcherbina L; Oskolkov N; Zhang E; Thevenin T; Fadista J; Bennet H; Vikman P; Wierup N; Fex M; Rung J; Wollheim C; Nobrega M; Renström E; Groop L; Hansson O
Hum Mol Genet; 2014 Dec; 23(24):6419-31. PubMed ID: 25015099
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of T2D-associated SNP effects on baseline and ER stress-responsive β cell transcriptional activation.
Khetan S; Kales S; Kursawe R; Jillette A; Ulirsch JC; Reilly SK; Ucar D; Tewhey R; Stitzel ML
Nat Commun; 2021 Sep; 12(1):5242. PubMed ID: 34475398
[TBL] [Abstract][Full Text] [Related]
8. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
Nordman S; Ostenson CG; Efendic S; Gu HF
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):186-90. PubMed ID: 19053027
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
[TBL] [Abstract][Full Text] [Related]
10. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants.
Parker SC; Stitzel ML; Taylor DL; Orozco JM; Erdos MR; Akiyama JA; van Bueren KL; Chines PS; Narisu N; ; Black BL; Visel A; Pennacchio LA; Collins FS; ;
Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17921-6. PubMed ID: 24127591
[TBL] [Abstract][Full Text] [Related]
11. Association of the rs7903146 single nucleotide polymorphism at the Transcription Factor 7-like 2 (TCF7L2) locus with type 2 diabetes in Brazilian subjects.
Barra GB; Dutra LA; Watanabe SC; Costa PG; Cruz PS; Azevedo MF; Amato AA
Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):479-84. PubMed ID: 23295285
[TBL] [Abstract][Full Text] [Related]
12. Genetic regulatory signatures underlying islet gene expression and type 2 diabetes.
Varshney A; Scott LJ; Welch RP; Erdos MR; Chines PS; Narisu N; Albanus RD; Orchard P; Wolford BN; Kursawe R; Vadlamudi S; Cannon ME; Didion JP; Hensley J; Kirilusha A; ; Bonnycastle LL; Taylor DL; Watanabe R; Mohlke KL; Boehnke M; Collins FS; Parker SC; Stitzel ML
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2301-2306. PubMed ID: 28193859
[TBL] [Abstract][Full Text] [Related]
13. Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus.
Fogarty MP; Cannon ME; Vadlamudi S; Gaulton KJ; Mohlke KL
PLoS Genet; 2014 Sep; 10(9):e1004633. PubMed ID: 25211022
[TBL] [Abstract][Full Text] [Related]
14. TCF7L2 plays a complex role in human adipose progenitor biology, which might contribute to genetic susceptibility to type 2 diabetes.
Verma M; Loh NY; Sabaratnam R; Vasan SK; van Dam AD; Todorčević M; Neville MJ; Toledo E; Karpe F; Christodoulides C
Metabolism; 2022 Aug; 133():155240. PubMed ID: 35697299
[TBL] [Abstract][Full Text] [Related]
15. Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D.
Viñuela A; Varshney A; van de Bunt M; Prasad RB; Asplund O; Bennett A; Boehnke M; Brown AA; Erdos MR; Fadista J; Hansson O; Hatem G; Howald C; Iyengar AK; Johnson P; Krus U; MacDonald PE; Mahajan A; Manning Fox JE; Narisu N; Nylander V; Orchard P; Oskolkov N; Panousis NI; Payne A; Stitzel ML; Vadlamudi S; Welch R; Collins FS; Mohlke KL; Gloyn AL; Scott LJ; Dermitzakis ET; Groop L; Parker SCJ; McCarthy MI
Nat Commun; 2020 Sep; 11(1):4912. PubMed ID: 32999275
[TBL] [Abstract][Full Text] [Related]
16. Replication and Relevance of Multiple Susceptibility Loci Discovered from Genome Wide Association Studies for Type 2 Diabetes in an Indian Population.
Phani NM; Adhikari P; Nagri SK; D'Souza SC; Satyamoorthy K; Rai PS
PLoS One; 2016; 11(6):e0157364. PubMed ID: 27310578
[TBL] [Abstract][Full Text] [Related]
17. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
Wasserman NF; Aneas I; Nobrega MA
Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891
[TBL] [Abstract][Full Text] [Related]
18. Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population.
Plengvidhya N; Chanprasert C; Chongjaroen N; Yenchitsomanus PT; Homsanit M; Tangjittipokin W
BMC Med Genet; 2018 Jun; 19(1):93. PubMed ID: 29871606
[TBL] [Abstract][Full Text] [Related]
19. The type 2 diabetes associated rs7903146 T allele within TCF7L2 is significantly under-represented in Hereditary Multiple Exostoses: insights into pathogenesis.
Sgariglia F; Pedrini E; Bradfield JP; Bhatti TR; D'Adamo P; Dormans JP; Gunawardena AT; Hakonarson H; Hecht JT; Sangiorgi L; Pacifici M; Enomoto-Iwamoto M; Grant SF
Bone; 2015 Mar; 72():123-7. PubMed ID: 25498973
[TBL] [Abstract][Full Text] [Related]
20. KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.
Song J; Yang Y; Mauvais-Jarvis F; Wang YP; Niu T
BMC Med Genet; 2017 Jun; 18(1):64. PubMed ID: 28587604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
